Reshma Kewalramani is the Chief Executive Officer and President of Vertex Pharmaceuticals. Reshma has held the CEO seat since April 2020, and was previously Vice President, Head US Medical Organization at Amgen.
Current company
Vertex Pharmaceuticals
Vertex Pharmaceuticals is an American pharmaceutical company.
pharmaceutical industryHeadquartered in BostonFounded 1989Nasdaq: VRTX
Source: WikidataReshma Kewalramani joined Vertex Pharmaceuticals in February 2017 and has been CEO since April 2020. Before Vertex Pharmaceuticals, Reshma was Vice President, Head US Medical Organization at Amgen from June 2014 until January 2017.
Career
Sources: LinkedIn profile
Education
Harvard Business School, General Management Program, General Management ProgramBoston University School of Medicine, Doctor of Medicine (M.D.), Seven Year Liberal Arts/Medical Education ProgramBoston University, Doctor of Medicine (M.D.), Seven Year Liberal Arts/Medical Education ProgramSource
180+ decision makers at Vertex Pharmaceuticals in Unify, vice president level and above. Choose a function to see who leads it.
Top decision makers at Vertex Pharmaceuticals
Vice president level and above, most senior firstReshma Kewalramani leads a leadership team of 11 published executives. The most recent appointment is Mark Bunnage as Executive Vice President, Chief Scientific Officer, in seat since February 2026.
Most senior 5 of 11
| Name | Title | In seat since |
|---|---|---|
| Reshma Kewalramani | Chief Executive Officer and President | April 2020 |
| Jeffrey M. Leiden | Executive Chairman | April 2020 |
| Charles F. Wagner Jr. | Executive Vice President, Chief Operating and Financial Officer | July 2025 |
| Jonathan Biller | Executive Vice President, Chief Legal Officer | September 2022 |
| Duncan J. McKechnie | Executive Vice President, Chief Commercial Officer | July 2025 |
Reshma Kewalramani is the Chief Executive Officer and President of Vertex Pharmaceuticals. Reshma has held the CEO seat since April 2020, and was previously Vice President, Head US Medical Organization at Amgen.
Reshma Kewalramani has been CEO of Vertex Pharmaceuticals since April 2020, according to LinkedIn profile.
Reshma Kewalramani was Vice President, Head US Medical Organization at Amgen from June 2014 until January 2017, according to LinkedIn profile.
Reshma Kewalramani has been CEO of Vertex Pharmaceuticals for 6 years, since April 2020.
Jeffrey M. Leiden (Executive Chairman), Charles F. Wagner Jr. (Executive Vice President, Chief Operating and Financial Officer), Jonathan Biller (Executive Vice President, Chief Legal Officer), Duncan J. McKechnie (Executive Vice President, Chief Commercial Officer), and 6 more. Source: Vertex Pharmaceuticals 2025 Form 10-K.
The seat holder is identified in Unify's professional profile dataset, then confirmed against the company's published leadership page, its SEC filings, and Wikipedia before publication. Career and education rows carry the public document they were taken from. Leadership team membership follows the company's own leadership page; in-seat dates come from filings where available and otherwise from the profile record. Company figures are read from the Unify headcount page for the same company and are profile coverage measures, never company-reported workforce totals. The employee preview lists vice president and senior vice president level profiles by department. No personal contact details are published.
